A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late...

Area of Science:

• Oncology
• Genetics
• Radiation Therapy

Background:

• Late normal tissue toxicity is a significant concern in radiation therapy.
• Genetic factors influencing wound repair and inflammation may play a role in developing these toxicities.
• Racial and ethnic variations in genetic makeup are known to exist.

Purpose of the Study:

• To investigate if genetic polymorphisms in four key genes (HMOX1, NFE2L2, NOS3, TGFβ1) involved in wound repair and radiation response can predict normal tissue late effects.
• To determine if these genetic variations can serve as potential therapeutic targets.
• To explore potential racial differences in these genetic associations.

Main Methods:

• A prospective study analyzed DNA from 179 patients (80% breast/head and neck cancer) with diagnosed late normal tissue toxicity.
• Genetic polymorphisms in HMOX1, NFE2L2, NOS3, and TGFβ1 were examined.
• Allelic frequencies were compared between patient groups and the general American population, stratified by race (56% white, 43% African American).

Main Results:

• A long GT repeat in the HMOX1 promoter was linked to late effects in both African American and white patients.
• Specific SNPs in TGFβ1 (rs1800469) and NFE2L2 (rs6721961) associated with late effects in African Americans but not whites.
• Over 90% of African American patients with late effects carried at least one minor allele of these SNPs; 58% carried two or more.
• No significant association was found between studied NOS3 polymorphisms and normal tissue toxicity.

Conclusions:

• The study confirms a strong link between wound repair genetic factors and late radiation toxicities.
• Genetic risk factors for radiation toxicity exhibit significant ethnic heterogeneity.
• Future research must incorporate ethnic variations when studying late radiation toxicities.